Evidence mapPaperPMID 42364039Full record

ReviewAbdominal radiology (New York)2026

Shifting from black box decisions to informed decision-making in using artificial intelligence to analyze prostate MRI.

Charlie Alexander Hamm, Enyu Yuan, Georg Lukas Baumgärtner, Adriano B Dias, Jeries Zawaideh, Giorgio Brembilla, Yuki Arita, Maarten de Rooij, Renato Cuocolo, Andrea Ponsiglione

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charlie Alexander HammDepartment of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Enyu YuanDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Georg Lukas BaumgärtnerDepartment of Radiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Adriano B DiasJoint Department of Medical Imaging, University Medical Imaging Toronto, University Health Network, Mount Sinai Hospital, and Women's College Hospital, University of Toronto, Toronto, Canada.
Jeries ZawaidehDepartment of Radiology, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi, Genoa, Italy.
Giorgio BrembillaDepartment of Radiology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Yuki AritaDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, USA.
Maarten de RooijDepartment of Medical Imaging, Radboud University Medical Center, Nijmegen, Netherlands.
Renato CuocoloDepartment of Medicine, Surgery, and Dentistry, University of Salerno, Baronissi, Italy.
Andrea PonsiglioneDepartment of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. A.ponsiglionemd@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate magnetic resonance imaging (MRI) is central to the detection and localization of clinically significant prostate cancers. However, its interpretation is time-consuming and variable. Artificial intelligence (AI) tools for prostate MRI are rapidly emerging, with their performance approaching that of expert readers in select settings, although robust external validation in unselected real-world cohorts remains incomplete. Moreover, many deep learning models are limited in terms of transparency; that is, the "black box" problem hinders trust, safe deployment, and regulatory acceptance. This review summarizes the core concepts of interpretability and explainable artificial intelligence (XAI), highlights commonly used approaches to explain the output of AI models, and discusses how the lack of transparency hinders clinical deployment and how this can be addressed using standardized reporting frameworks. Ultimately, the purpose of this review is to draw attention to the pressing need for XAI and to spark interest and awareness of how standardized frameworks may help us to shift from "black box" decisions to informed decision-making in clinical practice.

Indexed as

Artificial intelligenceDecision making, computer-assistedDeep learningMagnetic resonance imagingProstate neoplasms

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.